← Leaderboards
Fred Volinsky
Epiphany Biosciences, Inc.
$1,500,000
Attributed
$3,000,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2017–19$1M$750K$500K$250K$0
'17
'18
'19
Funding mix
By agency
NIH$3,000,000 · 1
By mechanism
R44$3,000,000 · 1
Top collaborators
- Enrique A Mesri3 shared
Others in their field
Other Emerging Leaders on “Acquired Immunodeficiency Syndrome”
- Kimberly Smith · Ppd Development Lp$122,008,792
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Leonard Freedman · Leidos Biomedical Research, Inc.$67,132,816
- Bambra Strokes · Ppd Development Lp$65,000,267
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Carina Remgsamai-Nhe · Fisher Bioservices, Inc.$44,034,909
Research focus
Acquired Immunodeficiency SyndromeAlgorithmsAnalytical MethodAntibodiesAntigensAntiretroviral TherapyAreaBaseBiomedical ResearchBlindedBloodBlood DonorBlood SpecimenCd4 Lymphocyte CountCenters For Disease Control And Prevention (U.S.)ChemopreventionClinical DiagnosticsClinical ResearchCodeCohortCo-InfectionCollaborationsConsensusCost Effective
Grant awards (3)
Improved Diagnosis of Kaposi's Sarcoma-Associated Herpesvirus Infection$1,000,000
R44 · FY2019 · AI · contact PI
Improved Diagnosis of Kaposi's Sarcoma-Associated Herpesvirus Infection$1,000,000
R44 · FY2018 · AI · contact PI
Improved Diagnosis of Kaposi's Sarcoma-Associated Herpesvirus Infection$1,000,000
R44 · FY2017 · AI · contact PI